Research·October 24, 2026 at 6:00 AM EDT·1 source
Cancer vaccine data from #ESMO26; Treasury proposal could curb China investment; and more
MRK -1.3%MRNA
MRK · last 30 trading days-1.3% since the news
News
What happened
- Endpoints Weekly reported from Madrid on cancer-vaccine data presented at ESMO26.
- The newsletter also covered a Treasury proposal that could curb investment in China.
- The most anticipated conference readout was Merck and Moderna’s Phase 3 study.
Why it matters
The items may matter to healthcare investors tracking late-stage cancer-vaccine data and to finance professionals monitoring potential restrictions on China investment.
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 21Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
- EarlierOct 23Tango combo clears Rasonque bar, Takeda's Innovent bet gets early returns, plus more from #ESMO26
- EarlierOct 23The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- EarlierYesterdayModerna Investors Should Brace for More Whiplash
- First reported by Endpoints NewsYesterdayCancer vaccine data from #ESMO26; Treasury proposal could curb China investment; and more
Who is involved
Cancer vaccine data from #ESMO26; Treasury proposal could cur…MerckMRKModernaMRNAU.S. Treasury
CompanyAgency
Sources (1)
- Endpoints NewsYesterdayCancer vaccine data from #ESMO26; Treasury proposal could curb China investment; and more
Related
- Yesterday · Wells Fargo, Cisco, Marvell among latest firms objecting to OKXICE's tokenized stock plan
- Oct 21 · Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
- Yesterday · STAT+: The ESMO presentation everyone’s been waiting for
- Yesterday · Moderna Investors Should Brace for More Whiplash
- Oct 23 · The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Oct 23 · Tango combo clears Rasonque bar, Takeda's Innovent bet gets early returns, plus more from #ESMO26
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.